(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Netanyahu vows to ‘return Negev to Israel,’ pledges settlement growth during visit - 2Dominating the Art of Composing: Creator Bits of knowledge
- 3Twins were the norm for our ancient primate ancestors − one baby at a time had evolutionary advantages
- 4‘Trip of suffering’: Gaza evacuee details 24-hour journey to South Africa
- 5Private sector revives the climate disaster database Trump tried to squash
- How a rare drug made from scientists' blood saves babies from botulism
- What will happen if Artemis 2 astronauts get hit by a solar storm during NASA's ambitious moon mission?
- Holiday spots Well known With Americans In 2024
- The Best 15 Applications for Efficiency and Association
- ‘Dying of thirst’: Inside Gaza’s al-Mawasi water crisis
- Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays
- Limited Rain Chances in Brazil Boost Coffee Prices
- Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- The Most Rousing Ladies Business visionaries of Today
